© 2020 MJH Life Sciences™ and Neurology Live. All rights reserved.
Weekly Recap
Pocket Card Treats Status Epilepticus, Pitolisant Shows No Cardiac Signals, SSRIs Associated With Increased Risk of Recurrent Stroke
September 12, 2020
Neurology News Network for the week ending September 12, 2020.
Lacosamide Meets Primary End Point, Lemborexant Well-Tolerated in Elders, Cala Trio Reduces Hand Tremor
September 05, 2020
Neurology News Network for the week ending September 5, 2020.
MS Physical Activity Recommendations, FDA Approves Celecoxib, Rituximab Effect on Myasthenia Gravis
May 09, 2020
Neurology News Network for the week ending May 9, 2020.
Risdiplam Meets End Point, Fenfluramine Effective in Treating Dravet Syndrome, Rimegepant Sees Early Results in Migraine
May 02, 2020
Neurology News Network for the week ending May 2.
Daridorexant Improves Daytime Sleepiness, Vutrisiran Gains Fast Track Designation, Erenumab Effective in Migraine
April 25, 2020
Neurology News Network for the week ending April 25, 2020.
Neurologic Symtpoms of COVID19, Rimegepant Available Via Telemedicine, Natalizumab
April 18, 2020
Neurology News Network for the week ending April 18, 2020.
Risdiplam PDUFA Pushed Back, Masitinib Gains NDA, COVID19 Affects CNS
April 11, 2020
Neurology News Network for the week ending April 11, 2020.
CBD Under FDA Review, Rimegepant Meets Endpoint, Sleep-Disordered Breathing Associated With Alzheimer Disease
April 04, 2020
Neurology News Network for the week ending April 4, 2020.
Teleheath Webinar on COVID-19 Now Available, Coronavirus' Effect on MS Patients, New Mind Moments Podcast
March 21, 2020
Neurology News Network for the week ending March 21, 2020.
Cenobamate Gets Schedule V Designation, ICER Publishes Migraine Treatment Review, FDA Approves RNS System Labeling Update
March 14, 2020
Neurology News Network for the week ending March 14, 2020.
FDA Approves Rimegepant, Results on Ofatumumab Trial, Diazepam Becomes Commercially Available
March 07, 2020
Neurology News Network for the week ending March 7, 2020.
Augusto Miravalle, MD: How Cladribine Sets Itself Apart in MS
March 06, 2020
The associate professor in the department of neurology at the University of Colorado and neurologist at Advanced Neurology of Colorado discussed the advantages of cladribine and details of the ongoing CLICK-MS study.
Huntington Disease Trial Results; Mind Moments Podcast Now Live; PMM Trial Falls Short
January 04, 2020
Neurology News Network for the week ending January 4, 2020.
CBD Reduces Seizures in Tuberous Sclerosis Complex, Fenfluramine Reduces Seizure Frequency While Improving Executive Function, Intranasal Diazepam Effective to Treat Seizures Regardless of Usage Frequency
December 14, 2019
Neurology News Network for the week ending December 14, 2019.
Risdiplam Shows Positive Results in SMA, Study Trials for DMD Discontinued, Neflamapimod Granted Fast Track for Treatment of Dementia with Lewy Bodies
November 16, 2019
Neurology News Network for the week ending November 16, 2019.
Aducanumab Reversal Sends Drug to FDA, Cala Trio Reduces Hand Tremor, Ganaxolone Promising in Refractory Status Epilepticus
October 26, 2019
Neurology News Network for the week ending October 26, 2019.
Lasmiditan Approved for Acute Migraine, Istradefylline Now Available for Parkinson Off Episodes, Omaveloxolone Promising in Friedreich's Ataxia
October 19, 2019
Neurology News Network for the week ending October 19, 2019.
RimabotulinumtoxinB for Sialorrhea, Zogenix Resubmits Fenfluramine NDA, Long-Term Lemborexant Insomnia Data
October 05, 2019
Neurology News Network for the week ending October 5, 2019.
EMA Removes Pregnancy Contraindications From MS Drugs, Oral Tavapadon Effective in Early-Stage Parkinson Disease, Pimavanserin Reduces Depression in PD
September 28, 2019
Neurology News Network for the week ending September 28, 2019.
STOP 301 Trial of INP104 Initiated, Suvodirsen Gets Fast Track Designation, Siponimod EXPAND Data
September 21, 2019
Neurology News Network for the week ending September 21, 2019.